G I-150 (Ibandronate sodium 150 mg (base))

Pill imprint G I-150 has been identified as Ibandronate sodium 150 mg (base).

Ibandronate is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Images for G I-150 (Ibandronate sodium 150 mg (base))

Ibandronate sodium 150 mg (base) G I-150
Ibandronate sodium
Imprint:
G I-150
Strength:
150 mg (base)
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5215
Inactive Ingredients:
ammonia
ferrosoferric oxide
silicon dioxide
crospovidone
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
shellac
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)